Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2026)
1,731
Value
$120.8K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of NKTR by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,731$120.8K<0.1%−185−9.7%ReducedHolders
Q1 20261,916$137.9K<0.1%+656+52.1%AddedHolders
Q4 20251,260$53.3K<0.1%−550−30.4%ReducedHolders
Q3 20251,810$103.0K<0.1%−1,891−51.1%ReducedHolders
Q2 20253,701$95.6K<0.1%+362+10.8%AddedConverted for a 1-for-15 splitHolders
Q1 202550,085$34.1K<0.1%+36,085+257.8%AddedHolders
Q4 202414,000$13.0K<0.1%−3,000−17.6%ReducedHolders
Q3 202417,000$22.1K<0.1%00.0%UnchangedHolders
Q2 202417,000$21.1K<0.1%+17,000NewHolders
Q4 20230$00.0%−50,950−100.0%Sold outHolders
Q3 202350,950$30.3K<0.1%00.0%UnchangedHolders
Q2 202350,950$29.3K<0.1%−8,660−14.5%ReducedHolders
Q1 202359,610$41.9K<0.1%−2,239−3.6%ReducedHolders
Q4 202261,849$139.8K<0.1%−5,119−7.6%ReducedHolders
Q3 202266,968$215.0K<0.1%−2,527−3.6%ReducedHolders
Q2 202269,495$264.0K<0.1%−164,341−70.3%ReducedHolders
Q1 2022233,836$1.26M<0.1%+1,618+0.7%AddedHolders
Q4 2021232,218$3.14M<0.1%−15,144−6.1%ReducedHolders
Q3 2021247,362$4.44M<0.1%−22,901−8.5%ReducedHolders
Q2 2021270,263$4.64M<0.1%+969+0.4%AddedHolders
Q1 2021269,294$5.39M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.